By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Devgen NV 

Technologiepark 9

Zwijnaarde    9052  Belgium
Phone: 32-9-324-24-24 Fax: 32-9-324-24-25



Drug Discovery


Janssen Pharmaceutica Products, L.P.  Signed in 1998; development of a screening system to identify compounds inhibiting a signal transduction pathway active in a variety of pathologies.

Metabolex, Inc.  Signed in 2001; research collaboration focused on diabetes; both companies each employ their respective technologies to identify each others compounds' mechanism of action.

FMC Corporation  Signed in 1999, enlarged in 2001; insecticide discovery and development; committed research revenues of Euro 23 million, excluding milestones and royalties.

Company News
Syngenta AG (SYT) and Devgen NV Enter Insect Control Research Partnership 5/14/2012 10:46:44 AM
Devgen NV Strengthens Its Board Of Directors 6/1/2011 12:58:11 PM
Devgen NV: Shareholder Notification 4/21/2011 10:52:44 AM
Devgen NV and SHS Celebrate with the National Outstanding Farmers Association the Positive Customer Feedback of their Hybrid Rice DG 1 SHS in Indonesia 4/13/2011 11:36:58 AM
Transparency Information: Devgen NV 4/8/2011 10:33:48 AM
Devgen NV (Euronext, Brussels: DEVG) Successfully Completes a Private Placement for a Total Amount of € 26.8 Million 3/31/2011 9:41:45 AM
Devgen NV Appoints Cheminova as Distributor in Southern Europe for its Nematicide Devguard(R) 3/25/2011 10:23:27 AM
Devgen NV: Shareholder Notification 3/11/2011 11:06:21 AM
Devgen NV Announces its Business and Financial Results for the Year Ending 31 December 2010 3/4/2011 9:35:14 AM
Devgen NV: Shareholder Notification 9/2/2010 12:23:58 PM